(Q37220329)

19 August 2017

Short-term efficacy of monthly pamidronate infusion in patients with osteogenesis imperfecta (English)

1 reference

19 August 2017

osteogenesis imperfecta

0 references

author name string

Jin-Ho Choi

series ordinal

1

1 reference

PMCID

2693583

19 August 2017

Young-Lim Shin

series ordinal

2

1 reference

PMCID

2693583

19 August 2017

Han-Wook Yoo

series ordinal

3

1 reference

19 August 2017

1 April 2007

1 reference

Journal of Korean Medical Science

19 August 2017

1 reference

19 August 2017

22

1 reference

19 August 2017

2

1 reference

19 August 2017

209-212

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

19 August 2017

start time

1 January 2007

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Osteogenesis imperfecta

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693583

The role of bisphosphonates in diseases of childhood

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693583

The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693583

Modeling the benefits of pamidronate in children with osteogenesis imperfecta

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693583

Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693583

Bisphosphonates: an overview with special reference to alendronate

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693583

Bisphosphonates: from grandparents to grandchildren

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693583

Cyclic administration of pamidronate in children with severe osteogenesis imperfecta

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693583

Consistent linkage of dominantly inherited osteogenesis imperfecta to the type I collagen loci: COL1A1 and COL1A2.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693583

Genetic heterogeneity in osteogenesis imperfecta

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693583

Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693583

Long-term effects of bisphosphonates on the growing skeleton. Studies of young patients with severe osteoporosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693583

Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693583

Osteogenesis imperfecta types I, III, and IV: effect of pamidronate therapy on bone and mineral metabolism

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693583

Intravenous bisphosphonate therapy in children with osteogenesis imperfecta

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693583

Pamidronate treatment of osteogenesis imperfecta--lack of correlation between clinical severity, age at onset of treatment, predicted collagen mutation and treatment response

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693583

Cyclic pamidronate infusion improves bone mineralisation and reduces fracture incidence in osteogenesis imperfecta

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693583

Nonoperative treatment of osteogenesis imperfecta: orthotic and mobility management

3 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17449925

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Intravenous pamidronate treatment in osteogenesis imperfecta

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17449925

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17449925

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3346/JKMS.2007.22.2.209

1 reference

19 August 2017

1 reference

19 August 2017

1 reference

PMCID

2693583